PubCheF-1, a deep learning model that predicts literature-derived biological function directly from chemical structure, establishes that machine learning-based prediction of biological function derived from the language of scientific literature allows the identification of bioactive molecules at high hit rates, thereby accelerating therapeutic discovery.
Abstract
Understanding how molecular structure encodes biological function remains a grand challenge in drug discovery. Here, we present PubCheF-1, a deep learning model that predicts literature-derived biological function directly from chemical structure. PubCheF-1 was trained on a dataset linking molecules to labels derived from the scientific articles in which they appear, a strategy that connects disparate compounds through the language used to describe their functionalities. When tasked with identifying inhibitors of β-lactamases, including enzymes considered largely refractory to inhibition, PubCheF-1 predicted structurally distinct compounds that collectively have activity against all β-lactamase classes. Furthermore, hit compounds directly bind the enzyme active site, restore antibiotic efficacy in multidrug-resistant high-priority pathogens, and demonstrate potent activity in animal infection models. Together, these findings establish that machine learning-based prediction of biological function derived from the language of scientific literature allows the identification of bioactive molecules at high hit rates, thereby accelerating therapeutic discovery.
This mini review traces the evolution of AI-driven methods in protein research, from early residue-contact prediction using coevolutionary information to transformative breakthroughs, the rise of protein language models (PLMs), and the emerging era of generative design and functional modeling.
Guodong Min, Huan Peng· Methods in molecular biology· 0 citations
A high-resolution layer-by-layer interpretability analysis of 8 models from the ESM2 and AMPLIFY families on 22 concepts from human proteome annotations found that these models encode concepts of increasing levels of complexity along their depth: basic physicochemical properties and linear motifs are best captured by e...
Shawn T. Whitfield, Tom Marty, Robert M. Vernon et al.· bioRxiv· 0 citations
Vilya-2 is the structure-prediction oracle that de novo peptide design pipelines require--establishing the all-atom approach as a general foundation for the design and evaluation of de novo peptide therapeutics.
Pascal Sturmfels, Naozumi Hiranuma, Milad Salem et al.· arXiv.org· 0 citations
By integrating disease-specific context into molecular generation, DrugGen-2 advances AI-assisted drug discovery, offering a powerful tool for de novo design and drug repurposing that accounts for the complex interplay between diseases and molecular targets.
Ali Motahharynia, Mohammadreza Ghaffarzadeh-Esfahani, Mahsa Sheikholeslami et al.· 0 citations
This review provides a systematic overview of recent advances in SSL-based molecular property prediction and analyzes how multimodal molecular representation learning by integrating sequence, graph, three-dimensional structure, and textual information can improve the quality and expressiveness of molecular representati...
Shuning Yang, Lei Deng· Journal of Chemical Informat...· 0 citations
LINKER is the first sequence-based model to predict residue-functional group interactions according to biologically defined interaction types, using only a protein sequence and the SMILES representation of the ligand, and requires only sequence-level input at inference.
Phuc Pham, Viet Thanh Duy Nguyen, Kevin Song et al.· Journal of Chemical Informat...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.